Tag: GHP Capital
Latest articles
Kite announces new Yescarta® data from pivotal ZUMA-1 trial
Kite announces new Yescarta® data from pivotal ZUMA-1 trial. The new data from the pivotal ZUMA-1 trial of Yescarta® (axicabtagene ciloleucel) showed that approximately...
AstraZeneca and MSD’s Lynparza™ now available in Scotland
AstraZeneca and MSD's Lynparza™ is now available in Scotland as the companies announce that olaparib monotherapy is now accepted for use by the Scottish...
How are LifeArc collaborating to advance research and science for patient benefit?
Melanie Lee CBE is Chief Executive of LifeArc, a self-funded medical research charity that is working in collaboration to translate early science for patient...
Popular articles
Living well with HIV and AIDS around the world
1st December is World AIDS Day which raises awareness of HIV and AIDS around the world. There have been huge leaps in the treatment...
How are LifeArc collaborating to advance research and science for patient benefit?
Melanie Lee CBE is Chief Executive of LifeArc, a self-funded medical research charity that is working in collaboration to translate early science for patient...
Merging CCGs to align commissioning
Julie Das-Thompson, Head of Policy and Delivery at NHS Clinical Commissioners, researches how 2020 will see the merging of at least 20 clinical commissioning...
Kite announces new Yescarta® data from pivotal ZUMA-1 trial
Kite announces new Yescarta® data from pivotal ZUMA-1 trial. The new data from the pivotal ZUMA-1 trial of Yescarta® (axicabtagene ciloleucel) showed that approximately...
Nurofen launches a 24 hour ibuprofen pain relief patch
Nurofen announces the launch of the UK’s only 24 hour clinically proven pain relief patch containing ibuprofen. Despite body pain being among the most commonly...